TPG Inc. stock has fallen sharply from its 52-week high of about $70 to around $44, but the company’s financials remain strong. Fee-related earnings increased by 43% and fee-earning assets under management (AUM) rose 24%, indicating solid growth. Additionally, $51.7 billion of AUM is not yet generating full fees, suggesting significant future revenue opportunities. Key risks include potential stalls in fee growth or realizations and the possibility that Q2’s high margins may not continue into Q3.
TPG Inc. and its financials are presented here alongside Pluang's Financials-sector snapshot for context. For readers following Financials-sector US stocks on Pluang as of Oct 01, 2026 22:02 WIB: out of 85 stocks, 16 rose and 69 fell. Among notable movers, CLSK dropped 4.04% to USD 12.36 with 98% sell orders, ING declined 4.00% to USD 34.08 with a typical hold time of 93 days, while SAN decreased 3.90% to USD 13.29 but saw 94% buy orders and a 55-day hold time.
Piper Sandler has set a $16 price target for V.F. Corp., suggesting a 12.2% upside from its current price of around $14.27. Analysts expect a slight decline in earnings per share to $0.51 and revenue to $2.70 billion, down 1.92% and 3.81% respectivel...
Raymond James increased its price target for e.l.f. Beauty from $100 to $117, reflecting the brand's significant retail expansion. e.l.f. Beauty's rhode brand is launching in over 500 Sephora stores across 19 new European markets, marking its first r...
Beneficient is set to report its Q3 2026 earnings on October 5, with analysts expecting $0.97 EPS and $13.1 million in revenue. The company is involved in disputes over allegedly fraudulent debt and equity claims linked to HCLP Nominees and former CE...
Robinhood Markets is broadening its platform with new features like AI-powered Robinhood Agents, crypto perpetual futures, earnings contracts, and social investing tools. The company plans to offer 24/7 trading for select U.S. stocks and ETFs, plus e...
Rosen Law Firm has filed a class action lawsuit on behalf of investors who purchased Celsius Holdings securities between February 2025 and June 2026. The lawsuit alleges Celsius failed to disclose cardiac risks associated with its Alani Nu products, ...
